Novanta Inc (NOVT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Novanta Inc stock (NOVT) is currently trading at $117.65. Novanta Inc PE ratio is 81.27. Novanta Inc PS ratio (Price-to-Sales) is 4.35. Analyst consensus price target for NOVT is $160.00. WallStSmart rates NOVT as Sell.
- NOVT PE ratio analysis and historical PE chart
- NOVT PS ratio (Price-to-Sales) history and trend
- NOVT intrinsic value — DCF, Graham Number, EPV models
- NOVT stock price prediction 2025 2026 2027 2028 2029 2030
- NOVT fair value vs current price
- NOVT insider transactions and insider buying
- Is NOVT undervalued or overvalued?
- Novanta Inc financial analysis — revenue, earnings, cash flow
- NOVT Piotroski F-Score and Altman Z-Score
- NOVT analyst price target and Smart Rating
Novanta Inc
📊 No data available
Try selecting a different time range
NOVT Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Novanta Inc (NOVT)
NOVT trades 1143% above its Graham fair value of $11.41, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Novanta Inc (NOVT) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in institutional own.. Concerns around return on equity and eps growth. Mixed signals suggest waiting for clearer direction before acting.
Novanta Inc (NOVT) Key Strengths (2)
114.23% of shares held by major funds and institutions
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
Novanta Inc (NOVT) Areas to Watch (8)
Earnings barely growing at 0.60%
Low profitability relative to shareholder equity
Paying a premium for growth, expensive relative to earnings expansion
Thin operating margins with cost pressures present
Premium valuation at 4.3x annual revenue
Premium pricing at 3.1x book value
Modest revenue growth at 8.50%
Thin profit margins with limited profitability
Supporting Valuation Data
Novanta Inc (NOVT) Detailed Analysis Report
Overall Assessment
This company scores 44/100 in our Smart Analysis, earning a D grade. Out of 10 metrics analyzed, 2 register as strengths (avg 8.5/10) while 8 fall into concern territory (avg 3.6/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Institutional Own., Market Cap.
The Bear Case
The primary concerns are EPS Growth, Return on Equity, PEG Ratio. Some valuation metrics including PEG Ratio (2.11), Price/Sales (4.35), Price/Book (3.09) suggest expensive pricing. Growth concerns include Revenue Growth at 8.50%, EPS Growth at 0.60%, which may limit upside. Profitability pressure is visible in Return on Equity at 5.23%, Operating Margin at 11.70%, Profit Margin at 5.49%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 5.23% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 8.50% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. EPS Growth and Return on Equity are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
NOVT Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
NOVT's Price-to-Sales ratio of 4.35x trades 18% below its historical average of 5.31x (28th percentile). The current valuation is 58% below its historical high of 10.45x set in Oct 2021, and 268% above its historical low of 1.18x in Jan 2016. Over the past 12 months, the PS ratio has compressed from ~4.9x as trailing revenue scaled faster than the stock price.
Compare NOVT with Competitors
Top SCIENTIFIC & TECHNICAL INSTRUMENTS stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Novanta Inc (NOVT) · TECHNOLOGY › SCIENTIFIC & TECHNICAL INSTRUMENTS
The Big Picture
Novanta Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 981M with 9% growth year-over-year. Profit margins are thin at 5.5%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Generating 5M in free cash flow and 9M in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Margin expansion: can Novanta Inc push profit margins above 15% as the business scales?
Valuation compression risk at a P/E of 81.3x. Any growth miss could trigger a sharp correction.
Volatility is elevated with a beta of 1.63, so expect amplified moves relative to the broader market.
Sector dynamics: monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive moves, and regulatory changes that could impact Novanta Inc.
Bottom Line
Novanta Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Novanta Inc(NOVT)
NASDAQ
TECHNOLOGY
SCIENTIFIC & TECHNICAL INSTRUM...
USA
Novanta Inc. designs, manufactures, markets and sells precision motion, vision and photonics components and subsystems to original equipment manufacturers in the medical and industrial markets worldwide. The company is headquartered in Bedford, Massachusetts.